carcinoma in situ of urinary bladder

DBCOND0106378NeoplasmsUrogenital Diseases

carcinoma in situ of urinary bladder is the indication for 6 drugs in DrugBank. It is covered by 9 curated, structured indications.

Also known as
Carcinoma in Situ of Bladder · carcinoma in situ of the urinary bladder · in situ Bladder Cancer
Classified under
Indicated drugs

Resolves to

Vocabularies
ICD-10D09.0SNOMED CT154638003MedDRA10005006UMLSC0154091

What you can answer from here — as of October 22, 2026

6Indicated drugsWith each drug's targets and mechanism
Listed above
9Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for carcinoma in situ of urinary bladder share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In